Delivery Order SPE2DB25D3018-SPE2DB26FUWRU
Award Date 10/17/25
Potential Completion Date 10/20/25
Potential Value $76K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain on May 12, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count quantity) with a contract ceiling value of $35,186.14. The award is a firm fixed price delivery order with an ultimate completion date of May 13, 2025, and represents a non-competitive, non-set-aside award. Performance will be conducted at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $41,661.01 by the Defense Logistics Agency on August 25, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count). The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of August 26, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $26,575.66 for MYRBETRIQ ER 50 mg tablets (90-count supply) from the Defense Logistics Agency Medical Supply Chain. The award was made on September 10, 2025, with an ultimate completion date of September 11, 2025, under a firm fixed-price contract type with no set-aside designation. This delivery order represents a competitive award to a qualified...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,135.26 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 and runs through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $36,113.23 on July 29, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by July 30, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,729.22 to AmerisourceBergen Drug Corp for the supply of Myrbetriq ER 50 mg tablets (30-count supply). This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of August 1, 2025, and represents a competitively awarded transaction under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Myrbetriq ER 50 mg tablets (90-count units) valued at $10,626.75. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was competitively procured. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of MYRBETRIQ ER 50 mg tablets (90-count units) valued at $3,217.23. This firm fixed-price contract, which was competitively awarded without set-aside designation, is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 10, 2025, for Myrbetriq ER 50 mg tablets (90-count supply). The contract is valued at $22,567.53 with a firm fixed price structure and an ultimate completion date of September 11, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,133.83 to AmerisourceBergen Drug Corp for MYRBETRIQ ER 50 MG tablets (90-count supply) on June 25, 2025, with completion targeted for June 26, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The pharmaceutical...